Identification of E6AP-independent degradation targets of HPV E6

References

1. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006; 24:S11–S25 [View Article]
   [Google Scholar]
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2:342–350 [View Article]
   [Google Scholar]
3. Androphy EJ, Hubbert NL, Schiller JT, Lowy DR. Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. Embo J 1987; 6:989–992 [View Article]
   [Google Scholar]
4. Gaglia MM, Munger K. More than just oncogenes: mechanisms of tumorigenesis by human viruses. Curr Opin Virol 2018; 32:48–59 [View Article]
   [Google Scholar]
5. Smotkin D, Wettstein FO. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 1986; 83:4680–4684 [View Article]
   [Google Scholar]
6. Thomas M, Banks L. Upsetting the balance: when viruses manipulate cell polarity control. J Mol Biol 2018; 430:3481–3503 [View Article]
   [Google Scholar]
7. Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001; 20:7888–7898 [View Article]
   [Google Scholar]
8. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63:1129–1136 [View Article]
   [Google Scholar]
9. Hengstermann A, D'silva MA, Kuballa P, Butz K, Hoppe-Seyler F et al. Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53. J Virol 2005; 79:9296–9300 [View Article]
   [Google Scholar]
10. Huibregtse JM, Scheffner M, Howley PM. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 1993; 13:775–784 [View Article]
    [Google Scholar]
11. Huibregtse JM, Scheffner M, Howley PM. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol 1993; 13:4918–4927 [View Article]
    [Google Scholar]
12. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75:495–505 [View Article]
    [Google Scholar]
13. Gardiol D, Kühne C, Glaunsinger B, Lee SS, Javier R et al. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 1999; 18:5487–5496 [View Article]
    [Google Scholar]
14. Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T et al. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 1997; 94:11612–11616 [View Article]
    [Google Scholar]
15. Nakagawa S, Huibregtse JM. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol 2000; 20:8244–8253 [View Article]
    [Google Scholar]
16. Thomas M, Laura R, Hepner K, Guccione E, Sawyers C et al. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 2002; 21:5088–5096 [View Article]
    [Google Scholar]
17. Thomas M, Massimi P, Navarro C, Borg JP, Banks L. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene 2005; 24:6222–6230 [View Article]
    [Google Scholar]
18. Javier RT. Cell polarity proteins: common targets for tumorigenic human viruses. Oncogene 2008; 27:7031–7046 [View Article]
    [Google Scholar]
19. Lee C, Laimins LA. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol 2004; 78:12366–12377 [View Article]
    [Google Scholar]
20. Handa K, Yugawa T, Narisawa-Saito M, Ohno SI, Fujita M et al. E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J Virol 2007; 81:1379–1389 [View Article]
    [Google Scholar]
21. Ye F, Zhang M. Structures and target recognition modes of PDZ domains: recurring themes and emerging pictures. Biochem J 2013; 455:1–14 [View Article]
    [Google Scholar]
22. Pim D, Bergant M, Boon SS, Ganti K, Kranjec C et al. Human papillomaviruses and the specificity of PDZ domain targeting. Febs J 2012; 279:3530–3537 [View Article]
    [Google Scholar]
23. Watson RA, Thomas M, Banks L, Roberts S. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J Cell Sci 2003; 116:4925–4934 [View Article]
    [Google Scholar]
24. Vande Pol SB, Klingelhutz AJ. Papillomavirus E6 oncoproteins. Virology 2013; 445:115–137 [View Article]
    [Google Scholar]
25. Tomaić V, Pim D, Banks L. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology 2009; 393:7–10 [View Article]
    [Google Scholar]
26. Thatte J, Banks L. Human papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 override the normal phosphoregulation of E6AP enzymatic activity. J Virol 2017; 91: [View Article]
    [Google Scholar]
27. Talis AL, Huibregtse JM, Howley PM. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem 1998; 273:6439–6445 [View Article]
    [Google Scholar]